These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections. Clark NM; Grim SA; Lynch JP Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia. Mattiuzzi G; Yilmaz M; Kantarjian H; Borthakur G; Konopleva M; Jabbour E; Brown Y; Pierce S; Cortes J J Infect Chemother; 2015 Sep; 21(9):663-7. PubMed ID: 26141814 [TBL] [Abstract][Full Text] [Related]
7. Visual Hallucinations Associated with High Posaconazole Concentrations in Serum. Parkes LO; Cheng MP; Sheppard DC Antimicrob Agents Chemother; 2016 Feb; 60(2):1170-1. PubMed ID: 26643343 [No Abstract] [Full Text] [Related]
12. Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation. Döring M; Cabanillas Stanchi KM; Queudeville M; Feucht J; Blaeschke F; Schlegel P; Feuchtinger T; Lang P; Müller I; Handgretinger R; Heinz WJ J Cancer Res Clin Oncol; 2017 Jul; 143(7):1281-1292. PubMed ID: 28258343 [TBL] [Abstract][Full Text] [Related]
13. Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole. Kidd D; Ranaghan EA; Morris TC Lancet; 1989 May; 1(8645):1017. PubMed ID: 2565490 [No Abstract] [Full Text] [Related]
14. Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia. Schrenk KG; Schnetzke U; Stegemann K; von Lilienfeld-Toal M; Hochhaus A; Scholl S J Cancer Res Clin Oncol; 2015 Sep; 141(9):1661-8. PubMed ID: 25800622 [TBL] [Abstract][Full Text] [Related]
15. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. Ullmann AJ; Lipton JH; Vesole DH; Chandrasekar P; Langston A; Tarantolo SR; Greinix H; Morais de Azevedo W; Reddy V; Boparai N; Pedicone L; Patino H; Durrant S N Engl J Med; 2007 Jan; 356(4):335-47. PubMed ID: 17251530 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Krishna G; Martinho M; Chandrasekar P; Ullmann AJ; Patino H Pharmacotherapy; 2007 Dec; 27(12):1627-36. PubMed ID: 18041883 [TBL] [Abstract][Full Text] [Related]
17. Posaconazole: an oral triazole with an extended spectrum of activity. Rachwalski EJ; Wieczorkiewicz JT; Scheetz MH Ann Pharmacother; 2008 Oct; 42(10):1429-38. PubMed ID: 18713852 [TBL] [Abstract][Full Text] [Related]
18. Posaconazole (Noxafil) for invasive fungal infections. Med Lett Drugs Ther; 2006 Nov; 48(1248):93-5. PubMed ID: 17106434 [No Abstract] [Full Text] [Related]
19. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan. Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977 [TBL] [Abstract][Full Text] [Related]